Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, ...

Understand how drug use increases HIV risk and learn about prevention strategies that save lives. Medical experts explain ...

Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...

Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral ...

An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...

It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New ...

Offering state HIV patients who qualify a six-month supply of antiretroviral pills at a time is one of the goals in the ...

Johnny Massaro and Bruna Linzmeyer star in Marcelo Gomes's ‘Oxygen Masks will (not) drop automatically’ about smuggling of ...

Millions in East Africa rely for their treatment on PEPFAR, a scheme launched by then-US president George W Bush in 2003.

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...